Mark Fineman
SVP, Clinical Operations and Pharmacovigilance @Travere Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
SVP, Clinical Operations and Pharmacovigilance @Travere Therapeutics
EDUCATION
California Polytechnic State University-San Luis Obispo
BS, Microbiology/Clinical Chemistry
Vrije Universiteit Amsterdam (VU Amsterdam)
PhD, Medicine
UC San Diego
MS, Molecular Pathology
UC San Diego
MAS, Clinical Research
SKILLS
ABOUT MARK FINEMAN
Chief Development/Scientific Officer/SVP with over thirty years of experience across all stages of pharmaceutical research & development. Experienced in building and leading R&D organizations in Clinical Research, Clinical Development, Regulatory Affairs, Pharmaceutics, Biometrics, Pharmacometrics and Medical Affairs. Successfully led teams through development, approval and commercialization of three first-in-class diabetes medicines (Byetta®, Bydureon®, Symlin®) and early and mid-stage development of several additional compounds across a wide-range of therapeutic areas.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.